متلازمة الإغراق عندما لم تُسيطر المكملات الغذائية والأكاربوز على الأعراض

References

DOI: 10.2147/CEG.S392265

It is generally agreed that OCT is the preferred treatment option for dumping symptoms in patients refractory to dietary measures and dietary supplements.

After an initial positive response to short-acting somatostatin analogues lasting from several weeks to months, patients can be converted to long-acting somatostatin analogues providing equal symptomatic benefit.

With respect to long-acting somatostatin analogues, several formulations are on the market: depot long-acting octreotide, pasireotide and lanreotide.

Dumping symptoms are reduced by 50%, and this efficacy remains present in long-term users both with short-acting and long-acting somatostatin analogues.